Repression of this PAX7 target gene score reliably hallmarks FSHD, has a robust association with pathology and associates with disease progression (Banerji & Zammit, 2019; Banerji, 2020). The gene discussed is PAX7; the disease is facioscapulohumeral muscular dystrophy.